Show Filters

Searches all publications.

Search Fulltext



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-23
    E.g., 2018-06-23


51060 items
12:00 AM, Jul 10, 2000  |  BC Extra | Financial News

Zycos raises $30.4 million

Zycos ( Cambridge, Mass.) raised $30.4 million in a venture round. Investors included Dresdner Kleinwort Benson; William Blair Capital Partners; Stephens Inc.; Sofinov; Oakwood Medical Investments; Medical Venture Partners; Lombard Odier; and New Medical Technologies....
12:00 AM, Jul 10, 2000  |  BC Extra | Financial News

Genome Therapeutics raises $46.5 million

Genomics play GENE sold 1.5 million shares at an average price of $31.01 per share in a private placement. Tucker Anthony served as placement agent....
12:00 AM, Jul 10, 2000  |  BC Extra | Financial News

Pharmagene updates IPO

Functional genomics company Pharmagene (Royston, U.K.) said its plans to raise about 40 million ($60 million) through the issue of 14.3 million shares at 240p-320p on the London Stock Exchange. An overallotment of 2.1 million...
12:00 AM, Jul 10, 2000  |  BC Extra | Financial News

IBT to increase cash-out

Shareholders agreed that International Biotechnology Trust (LSE:IBT) should return more cash to shareholders at last Friday's extraordinary general meeting, held at the demand of IBT's 10.06 percent shareholder, Millennium Partners (see BioCentury Extra, Friday...
12:00 AM, Jul 10, 2000  |  BC Extra | Top Story

Invitrogen buys Dexter and LTEK

IVGN entered into a definitive agreement to acquire DEX, a specialty materials supplier, and Life Technologies (LTEK), a life sciences applications supplier, for $1.9 billion in cash and stock. IVGN will acquire DEX, which owns...
12:00 AM, Jul 10, 2000  |  BC Extra | Clinical News

Chiron reports Phase II data

CHIR said data from a 78-patient study showed its Proleukin aldesleukin interleukin-2 plus standard antiretroviral therapy achieved significant increases in CD4+ T cell counts in asymptomatic HIV-infected patients without a sustained increase in the level...
12:00 AM, Jul 10, 2000  |  BC Extra | Company News

Clingenix makes two acquisitions

Pharmacogenomics company Clingenix (Sunnyvale, Calif.) acquired North Coast Clinical Laboratory (Sandusky, Ohio) and Research Services (Los Gatos, Calif.) Terms were not disclosed. North Coast, a clinical trial laboratory, and RSI, a CRO, will provide clinical...
12:00 AM, Jul 10, 2000  |  BC Extra | Company News

Cephalon nicked on Myotrophin report

CEPH closed Monday at $69.875, down $0.563, after the Washington Post reported that several current and former employees of the company had received subpoenas relating to a federal grand jury probe of the manufacture and...
12:00 AM, Jul 07, 2000  |  BC Extra | Company News

Orchid grants PEB access to SNP technology

PE Biosystems (PEB) received a non-exclusive license to ORCH's SNP-IT single base primer extension technology for single nucleotide polymorphism analysis. PEB will incorporate the technology in its ABI PRISM reagent kits....
12:00 AM, Jul 07, 2000  |  BC Extra | Top Story

IBT plays up to shareholders

The management of International Biotechnology Trust (LSE:IBT) is steadily caving in to the requests of Millennium Partners, its 10.06 percent shareholder. In a press release issued just prior to Friday's shareholder meeting, IBT said it...